Exact Mass: 613.1625

Exact Mass Matches: 613.1625

Found 15 metabolites which its exact mass value is equals to given mass value 613.1625, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Glucosinalbin 4-(4-acetylrhamnoside)

{[(e)-[2-(4-{[5-(acetyloxy)-3,4-dihydroxy-6-methyloxan-2-yl]oxy}phenyl)-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulphanyl}ethylidene]amino]oxy}sulphonic acid

C22H31NO15S2 (613.1135)

Glucosinalbin 4-(4-acetylrhamnoside) is found in fats and oils. Glucosinalbin 4-(4-acetylrhamnoside) is a constituent of Moringa oleifera (horseradish tree) and Moringa peregrina. Constituent of Moringa oleifera (horseradish tree) and Moringa peregrina. Glucosinalbin 4-(4-acetylrhamnoside) is found in fats and oils, herbs and spices, and green vegetables.

convolutamide D|N-(9Z-Octadecenoyl)-Deacylconvolutamide

C28H41Br2NO4 (613.1402)

Mosapride citrate

C27H33ClFN3O10 (613.1838)

D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D017366 - Serotonin Receptor Agonists D005765 - Gastrointestinal Agents Mosapride citrate is an orally active gastroenterokinetic compound. Mosapride citrate is a 5HT4 agonist. Mosapride citrate is a CYP inducer. Mosapride citrate has a concentration-dependent inhibitory effect on Kv4.3, and its IC50 value is 15.2 μM. Mosapride citrate can be used in the study of gastrointestinal diseases[1][2][3][4][5][6][7].

Glucosinalbin 4-(4-acetylrhamnoside)

{[(E)-[2-(4-{[5-(acetyloxy)-3,4-dihydroxy-6-methyloxan-2-yl]oxy}phenyl)-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanyl}ethylidene]amino]oxy}sulfonic acid

C22H31NO15S2 (613.1135)

Protected Imipenem

C27H27N5O10S (613.1479)

3-[3-(3-Carboxypropionyl)ureido]-2-methoxypropyl(1,2,3,6-tetrahydro-1,3-dimethyl-2,6-dioxo-7H-purin-7-yl)mercury(II)

C16H23HgN6O7 (613.1334)

Fosifloxuridine nafalbenamide

C29H29FN3O9P (613.1625)

C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C272 - Antimetabolite C471 - Enzyme Inhibitor > C2021 - Thymidylate Synthase Inhibitor

N-[2-[4-[[[2-[(Hydroxyamino)carbonyl]-4,6-dimethylphenyl](phenylmethyl)amino]sulfonyl]phenoxy]ethyl]-2-benzofurancarboxamide

C33H31N3O7S (613.1883)

1-(6-{2-[({3-methyl-4-[(trifluoromethyl)oxy]-4-biphenylyl}methyl)oxy]phenyl}-2-pyridinyl)-5-(trifluoromethyl)-1H-pyrazole-4-carboxylic acid

C31H21F6N3O4 (613.1436)

3-(3,4-dibromo-5-hydroxyphenyl)-3-hydroxy-1-(octadec-9-enoyl)pyrrolidin-2-one

C28H41Br2NO4 (613.1402)

[(z)-[2-(4-{[(2s,3s,4r,5r,6s)-5-(acetyloxy)-3,4-dihydroxy-6-methyloxan-2-yl]oxy}phenyl)-1-{[(2r,3r,4r,5s,6s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanyl}ethylidene]amino]oxysulfonic acid

C22H31NO15S2 (613.1135)

3,5,10,28-tetrahydroxy-7-methyl-26-oxo-14,16,19-trioxa-6-azaheptacyclo[15.11.1.0²,¹¹.0⁴,⁹.0¹³,²⁹.0¹⁸,²⁷.0²⁰,²⁵]nonacosa-1(29),2,4,6,8,10,17,22,27-nonaen-21-yl octa-2,4-dienoate

3,5,10,28-tetrahydroxy-7-methyl-26-oxo-14,16,19-trioxa-6-azaheptacyclo[15.11.1.0²,¹¹.0⁴,⁹.0¹³,²⁹.0¹⁸,²⁷.0²⁰,²⁵]nonacosa-1(29),2,4,6,8,10,17,22,27-nonaen-21-yl octa-2,4-dienoate

C34H31NO10 (613.1948)

(13r,20r,21s,25s)-3,5,10,28-tetrahydroxy-7-methyl-26-oxo-14,16,19-trioxa-6-azaheptacyclo[15.11.1.0²,¹¹.0⁴,⁹.0¹³,²⁹.0¹⁸,²⁷.0²⁰,²⁵]nonacosa-1(29),2,4,6,8,10,17,22,27-nonaen-21-yl (2e,4e)-octa-2,4-dienoate

(13r,20r,21s,25s)-3,5,10,28-tetrahydroxy-7-methyl-26-oxo-14,16,19-trioxa-6-azaheptacyclo[15.11.1.0²,¹¹.0⁴,⁹.0¹³,²⁹.0¹⁸,²⁷.0²⁰,²⁵]nonacosa-1(29),2,4,6,8,10,17,22,27-nonaen-21-yl (2e,4e)-octa-2,4-dienoate

C34H31NO10 (613.1948)

(3s)-3-(3,4-dibromo-5-hydroxyphenyl)-3-hydroxy-1-[(9z)-octadec-9-enoyl]pyrrolidin-2-one

C28H41Br2NO4 (613.1402)

2,5-dihydroxy-10-(2-hydroxy-5-{2-hydroxy-4-[(4-hydroxy-3-methoxyphenyl)methyl]-5h-pyrrol-3-yl}phenyl)-6,8-dimethoxy-2-methyl-3h-naphtho[2,3-b]pyran-4-one

C34H31NO10 (613.1948)